1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
10
|
11
|
12
|
13
|
14
|
15
|
16
|
17
|
18
|
19
|
---|
Yuan 2017 [4]
|
SD
|
M
|
330–350 g
|
5000 m altitude
|
6 h/day
|
28 days
|
G
|
30
|
120
|
sodium pentobarbital
|
IR/VR
|
Means±SD
|
4
|
12.8
|
2.0
|
4
|
38.4
|
5
|
Li 2016 [24]
|
SD
|
M
|
220 ±? g
|
5000 m altitude
|
6 h/day
|
28 days
|
G
|
30
|
120
|
sodium pentobarbital
|
IR/VR
|
Means±SD
|
6
|
27.3
|
5.9
|
6
|
48.3
|
7.5
|
Kasparova 2015 [3]
|
W
|
M
|
300–380 g
|
Normobaric FiO2 10%
|
8 h/day
|
21 days
|
LAD
|
20
|
180
|
Sodium pentobarbital
|
IR/AAR
|
Means±SE
|
10
|
46.4
|
4.2
|
10
|
62.7
|
2.7
|
Meng 2014 [25]
|
W
|
M
|
150–180 g
|
5000 m altitude
|
6 h/day
|
42 days
|
LAD
|
30
|
240
|
25% ethylurethanm solution
|
IR/AAR
|
Means±SE
|
7
|
12.5
|
1.6
|
7
|
30.9
|
6.8
|
Ma 2014 [26]
|
SD
|
M
|
neonate
|
3000 m altitude
|
5 h/day
|
42 days
|
G
|
30
|
120
|
sodium pentobarbital
|
IR/VR
|
Means±SE
|
6
|
26.7
|
0.4
|
6
|
48.6
|
2.2
|
Gao 2014 [27]
|
SD
|
M
|
100–130 g
|
5000 m altitude
|
4 h/day
|
28 days
|
G
|
30
|
120
|
sodium pentobarbital
|
IR/AAR
|
Means±SE
|
5
|
22.58
|
3
|
5
|
35.9
|
4.1
|
Manukhina 2013 [28]
|
W
|
M
|
250–280 g
|
Normobaric FiO2 9.5–10%
|
4 min/cycle
|
5–8 cycles/day 20 days
|
LAD
|
30
|
120
|
urethane
|
IR/AAR
|
Means±SE
|
10
|
17.5
|
2.6
|
9
|
30.6
|
5.1
|
Ramond 2013a [16]
|
W
|
M
|
250–350 g
|
Normobaric FiO2 5%
|
40s/min 8 h/d
|
14 days
|
G
|
30
|
120
|
sodium pentobarbital
|
IR/VR
|
Means±SE
|
7
|
36.0
|
2.8
|
7
|
21.8
|
3.1
|
Ramond 2013b [16]
|
W
|
M
|
250–350 g
|
Normobaric FiO2 5%
|
40s/min 8 h/d
|
14 days
|
G
|
30
|
120
|
sodium pentobarbital
|
IR/VR
|
Means±SE
|
8
|
40.3
|
3.5
|
8
|
29.4
|
3.7
|
Milano 2011 [17]
|
SD
|
M
|
251 ± 2 g
|
Normobaric FiO2 10%
|
23 h/day
|
15 days
|
LAD
|
30
|
180
|
sodium pentobarbital
|
IR/AAR
|
Means±SE
|
7
|
68.5
|
2.4
|
7
|
46.5
|
4.4
|
Wang 2011 [29]
|
SD
|
M
|
100–120 g
|
5000 m altitude
|
4 h/day
|
28 days
|
G
|
30
|
120
|
pentobarbital sodium
|
IR/AAR
|
Means±SE
|
5
|
20.5
|
5.3
|
5
|
42.1
|
3.8
|
Belaidi 2008 [30]
|
W
|
M
|
330–350 g
|
Normobaric FiO2 10%
|
4 h/day
|
1 day
|
G
|
30
|
120
|
pentobarbital sodium
|
IR/VR
|
Means±SE
|
8
|
15.9
|
5.6
|
8
|
33.8
|
5
|
Yeung 2007a [31]
|
SD
|
M
|
290–320 g
|
Normobaric FiO2 10%
|
6 h/day
|
3 days
|
LCA
|
30
|
120
|
decapitated
|
IR/AAR
|
Means±SE
|
6
|
32.7
|
1.2
|
6
|
35.1
|
1.8
|
Yeung 2007b [31]
|
SD
|
M
|
290–320 g
|
Normobaric FiO2 10%
|
6 h/day
|
7 days
|
LCA
|
30
|
120
|
decapitated
|
IR/AAR
|
Means±SE
|
6
|
26.5
|
0.7
|
6
|
34.8
|
1.1
|
Yeung 2007c [31]
|
SD
|
M
|
290–320 g
|
Normobaric FiO2 10%
|
6 h/day
|
14 days
|
LCA
|
30
|
120
|
decapitated
|
IR/AAR
|
Means±SE
|
6
|
31.71
|
1.0
|
6
|
37.7
|
2.0
|
Ravingerová 2007 [32]
|
W
|
M
|
250–280 g
|
7000 m altitude
|
8 h/day
|
5 days/week 25–30 days
|
LAD
|
20
|
180
|
sodium pentobarbiton
|
IR/AAR
|
Means±SE
|
8
|
51.8
|
4.4
|
8
|
64.9
|
5.1
|
Kolár 2007 [33]
|
W
|
M
|
250–280 g
|
7000 m altitude
|
8 h/day
|
24–30 days
|
LAD
|
20
|
180
|
sodium pentobarbital
|
IR/AAR
|
Means±SE
|
8
|
27.7
|
4.9
|
8
|
56.7
|
4.5
|
Béguin 2007 [34]
|
W
|
M
|
330–380 g
|
5000 m altitude
|
4 h/d
|
1 day
|
G
|
30
|
120
|
sodium pentobarbital
|
IR/VR
|
Means±SE
|
8
|
22.2
|
2.4
|
8
|
33.8
|
2.6
|
Zhu 2006 [35]
|
SD
|
M
|
100–130 g
|
5000 m altitude
|
6 h/day
|
42 days
|
G
|
30
|
120
|
sodium pentobarbital
|
IR/VR (LV area)
|
Means±SE
|
7
|
24
|
1.9
|
7
|
42.1
|
2.1
|
Kolár 2005 [36]
|
W
|
M
|
5–6 weeks
|
7000 m altitude
|
8 h/day
|
35–42 days
|
LAD
|
20
|
180
|
sodium pentobarbiton
|
IR/AAR
|
Means±SE
|
7
|
43.2
|
3.3
|
7
|
59.2
|
4.4
|
Béguin 2005 [37]
|
W
|
M
|
330–380 g
|
Normobaric FiO2 10%
|
40s/min 4 h/d
|
1d
|
G
|
30
|
120
|
sodium pentobarbiton
|
IR/VR (LV area)
|
Means±SE
|
11
|
21.8
|
3.1
|
9
|
33.5
|
2.5
|
Joyeux-Faure 2005 [38]
|
W
|
M
|
220–240 g
|
Normobaric FiO2 5%
|
40s/min 8 h/d
|
35 days
|
G
|
30
|
120
|
sodium pentobarbiton
|
IR/VR
|
Means±SE
|
9
|
46.9
|
3.6
|
9
|
26.1
|
2.8
|
Neckár 2005a [39]
|
W
|
M
|
250–280 g
|
7000 m altitude
|
8 h/day
|
24–32 days
|
LAD
|
20
|
180
|
sodium pentobarbital
|
IR/AAR
|
Means±SE
|
9
|
41.2
|
3.9
|
9
|
58.2
|
2.2
|
Neckár 2005b [39]
|
W
|
M
|
250–280 g
|
7000 m altitude
|
8 h/day
|
24–32 days
|
LAD
|
20
|
180
|
sodium pentobarbital
|
IR/AAR
|
Means±SE
|
9
|
33.9
|
3.8
|
9
|
58.9
|
3.7
|
Neckár 2004 [40]
|
W
|
M
|
250–280 g
|
7000 m altitude
|
8 h/day
|
5 days a week 35 days
|
LAD
|
30
|
240
|
sodium pentobarbiton
|
IR/AAR
|
Means±SE
|
11
|
48
|
2.2
|
15
|
69.2
|
1.7
|
Neckár 2002a [41]
|
W
|
M
|
250–280 g
|
5000 m altitude
|
8 h/day
|
5 days a week 24–32 days
|
G
|
20
|
240
|
sodium pentobarbiton
|
IR/AAR
|
Means±SE
|
16
|
52.7
|
2.5
|
10
|
62.2
|
2
|
Neckár 2002b [41]
|
W
|
M
|
250–280 g
|
5000 m altitude
|
8 h/day
|
5 days a week 24–32 days
|
G
|
20
|
240
|
sodium pentobarbiton
|
IR/AAR
|
Means±SE
|
9
|
51.5
|
2.2
|
9
|
60.2
|
2.6
|
Neckár 2002c [42]
|
W
|
M
|
250–280 g
|
7000 m altitude
|
8 h/day
|
5 days a week 24–30 days
|
LAD
|
30
|
240
|
sodium pentobarbiton
|
IR/AAR
|
Means±SE
|
19
|
50.2
|
1.9
|
10
|
66.6
|
2.3
|
- Different letters refer to different studies and experimental groups within each included study. SD, Sprague-Dawley rats; W, Wistar rats; M, male; 7000 m altitude (around PB 308 mmHg, PO2 65 mmHg, FiO2 9.75%), 5000 m altitude (around PB 404 mmHg, PO2 85 mmHg, FiO2 12.95%), 3000 m altitude (around PB 525 mmHg, PO2 110 mmHg, FiO2 14.4%), sea-level (around PB 760 mmHg, PO2 159 mmHg, FiO2 20.95%); G, global ischemia; LAD, left anterior descending; LCA, left coronary artery; IS, infarct size; VS, ventricle size; AAR, area at risk; SEM, standard error of the mean; STD, standard deviation of the mean. The main characteristics included (1) study, year, reference; (2) species; (3) sex; (4) age or weight; (5) oxygen concentration (Fi O2); (6) daily hypoxic exposure (hour); (7) total stimulus duration (day); (8) ligation of coronary artery; (9) duration of index ischemia duration (min); (10) reperfusion duration (h); (11) induction anesthetic; (12) measurement of IS; (13) measurement of variance; (14) control group sample size; (15) control group mean infarct size; (16) control group variance; (17) conditioning group sample size; (18) conditioning group mean infarct size; (19) conditioning group variance